The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1
Abstract
Phase I studies of volunteers not infected with human immunodeficiency virus type 1 (HIV-1) have shown that immunization with envelope subunit vaccine products elicits antibodies that neutralize laboratory-adapted (prototype) HIV-1 strains in vitro. Prototype strains are adapted to grow in continuous (neoplastic) cell lines and are more susceptible to neutralization than are primary isolates cultured in human peripheral blood mononuclear cells. In this study, 50 sera from nine phase I vaccine trials and 16 from HIV-1-infected persons were evaluated for neutralizing antibody activity against 3 laboratory-adapted and 5 primary HIV-1 isolates. Of 50 sera, 49 neutralized at least 1 of the prototype strains; however, none displayed neutralizing activity against primary isolates of HIV-1. Serum from most HIV-1-infected persons neutralized both laboratory-adapted and primary HIV-1 isolates. These data demonstrate a qualitative, or large quantitative, difference in the neutralizing antibody response induced by envelope subunit vaccination and natural HIV-1 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Pathogenesis of dengue: challenges to molecular biology
Halstead, S. (1988) · Science · doi:10.1126/science.239.4839.476 · Cited by 1,614
Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., et al. (1994) · Science · doi:10.1126/science.7973652 · Cited by 1,100
Cao, Y., Qin, L., Zhang, L., Safrit, J., & Ho, D. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320401 · Cited by 1,037
Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes
Delwart, E., Shpaer, E., Louwagie, J., McCutchan, F., Grez, M., Rubsamen-Waigmann, H., & Mullins, J. (1993) · Science · doi:10.1126/science.8235655 · Cited by 757
Self-citationPrincipal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. I., Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., & Putney, S. D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6768 · Cited by 618
Measles Antibody: Reevaluation of Protective Titers
Chen, R. T., Markowitz, L. E., Albrecht, P., Stewart, J. A., Mofenson, L. M., Preblud, S. R., & Orenstein, W. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1036 · Cited by 608
Berman, P. W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. P., Wurm, F. M., Hershberg, R. D., Cobb, E. K., & Eichberg, J. W. (1990) · Nature · doi:10.1038/345622a0 · Cited by 590
Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody
Emini, E. A., Schleif, W. A., Nunberg, J. H., Conley, A. J., Eda, Y., Tokiyoshi, S., Putney, S. D., Matsushrta, S., Cobb, K. E., Jett, C. M., et al. (1992) · Nature · doi:10.1038/355728a0 · Cited by 471
Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., Burton, D. R., & Ho, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.101-109.1995 · Cited by 401
Albert, J., Abrahamsson, B., Nagy, K., Aurelius, E., Gaines, H., Nyström, G., & Fenyö, E. M. (1990) · AIDS · doi:10.1097/00002030-199002000-00002 · Cited by 398
Neutralization of the AIDS Retrovirus by Antibodies to a Recombinant Envelope Glycoprotein
Lasky, L. A., Groopman, J. E., Fennie, C. W., Benz, P. M., Capon, D. J., Dowbenko, D. J., Nakamura, G. R., Nunes, W. M., Renz, M. E., & Berman, P. W. (1986) · Science · doi:10.1126/science.3014647 · Cited by 353
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
Girard, M., Kieny, M. P., Pinter, A., Barre-Sinoussi, F., Nara, P., Kolbe, H., Kusumi, K., Chaput, A., Reinhart, T., & Muchmore, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.542 · Cited by 352
Layne, S. P., Merges, M. J., Dembo, M., Spouge, J. L., Conley, S. R., Moore, J. P., Raina, J. L., Renz, H., Gelderblom, H. R., & Narat, P. L. (1992) · Virology · doi:10.1016/0042-6822(92)90593-e · Cited by 332
Moore, J. P., McKeating, J. A., Huang, Y. X., Ashkenazi, A., & Ho, D. D. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.235-243.1992 · Cited by 284
Moore, J. P., Cao, Y., Ho, D. D., & Koup, R. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5142-5155.1994 · Cited by 218
Neutralization of Animal Viruses
Dimmock, N. J. (1993) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-77849-0 · Cited by 180
Wrin, T., Loh, T. P., Vennari, J., Schuitemaker, H., & Nunberg, J. H. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.39-48.1995 · Cited by 142
Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.
Profy, A. T., Salinas, P. A., Eckler, L., Dunlop, N. M., Nara, P. L., & Putney, S. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.12.4641 · Cited by 124
EVALUATION OF RED CROSS GAMMA GLOBULIN AS A PROPHYLACTIC AGENT FOR POLIOMYELITIS
Hammon, W. M. (1952) · JAMA · doi:10.1001/jama.1952.03680080019003 · Cited by 105
Japour, A. J., Fiscus, S. A., Arduino, J. M., Mayers, D. L., Reichelderfer, P. S., & Kuritzkes, D. R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.9.2291-2294.1994 · Cited by 77
Baldinotti, F., Matteucci, D., Mazzetti, P., Giannelli, C., Bandecchi, P., Tozzini, F., & Bendinelli, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4572-4579.1994 · Cited by 74
O’Brien, W. A., Mao, S., Cao, Y., & Moore, J. P. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5264-5269.1994 · Cited by 56
Kovacs, J. A., Vasudevachari, M. B., Easter, M., Davey, R. T., Falloon, J., Polis, M. A., Metcalf, J. A., Salzman, N. P., Baseler, M., & Smith, G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116667 · Cited by 43
Immune reactions against rabies viruses -infection and vaccination
Süß, J., & Sinnecker, H. (1991) · Experimental Pathology · doi:10.1016/s0232-1513(11)80028-9 · Cited by 13
Cited by
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Self-citationChan, D. C., & Kim, P. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81430-0 · Cited by 1,277
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Self-citationHost factors and the pathogenesis of HIV-induced disease
Fauci, A. S. (1996) · Nature · doi:10.1038/384529a0 · Cited by 829
Mascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4009-4018.1999 · Cited by 783
Self-citation
Metadata
- Authors
- Mascola, J. R., Snyder, S. W., Weislow, O. S., Belay, S. M., Belshe, R. B., Schwartz, D. H., Clements, M. L., Dolin, R., Graham, B. S., Gorse, G. J., Keefer, M. C., McElrath, M. J., Walker, M. C., Wagner, K. F., McNeil, J. G., McCutchan, F. E., Burke, D. S., National Institute of Allergy and Infectious Diseases, & AIDS Vaccine Evaluation Group
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-02-01
- Volume
- 173
- Issue
- 2
- Pages
- 340-348
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2156557297
- Cited by
- 436
- References
- 25
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.